bioMérieux launches a proactive solution for Listeria risk control with VIDAS® LDUO
Marcy l'Etoile, France - April 10, 2006.
bioMérieux offers food-processing industries the world’s first proactive solution for Listeria risk control with VIDAS® LDUO.
VIDAS® LDUO innovation
bioMérieux’s new VIDAS® LDUO test now enables the simultaneous detection and differentiation of Listeria spp and Listeria monocytogenes in a single test for food products and environmental samples. bioMérieux’s know-how in immunoassays allows synthesis of antibody fragments which reduce non-specific interactions with food matrices for increased specificity. The use of these highly specific antibody fragments also improves sensitivity by more rapid diffusion in the sample. The combined use of VIDAS® LDUO with LX broth enables faster growth of bacteria for enhanced detection, outperforming the ISO standard 11290-1.
A proactive approach
By working in routine with the simultaneous detection of Listeria spp and Listeria monocytogenes, laboratories can improve their efficiency and better anticipate the risk of Listeria contamination. The use of Listeria spp as an early alert indicator reinforces the control of this pathogen. The immediate result for Listeria monocytogenes optimizes the confirmation procedure.
VIDAS® LDUO : officially validated by AFNOR/ISO 16140
VIDAS®, the world’s leading automated system for food-borne pathogen detection has recently obtained official validation by AFNOR in compliance with ISO 16140 (BIO-12/18-03/06) for its new and innovative solution for controlling the risk of Listeria: VIDAS® Listeria DUO. This marks the 30th official validation of the VIDAS® system.
Through its expertise in food testing and its knowledge of immunoassay development, bioMérieux is achieving new standards in industrial microbiological control. Our R&D teams are working on new high performance solutions for quality control laboratories in the food industry, using state-of-the-art technologies available in bioMérieux’s portfolio.
Listeria is known to be potentially present in food products and environmental samples, particularly in food processing plants. In humans, Listeria monocytogenes may cause severe pathologies, such as meningitis, septicaemia and encephalitis, as well as abortions. Groups at greatest risk include pregnant women, neonates, immunocompromised patients and the elderly.